SK288111B6 - Dermatological formulations - Google Patents

Dermatological formulations Download PDF

Info

Publication number
SK288111B6
SK288111B6 SK632-2003A SK6322003A SK288111B6 SK 288111 B6 SK288111 B6 SK 288111B6 SK 6322003 A SK6322003 A SK 6322003A SK 288111 B6 SK288111 B6 SK 288111B6
Authority
SK
Slovakia
Prior art keywords
composition according
formulations
composition
clindamycin phosphate
clindamycin
Prior art date
Application number
SK632-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK6322003A3 (en
Inventor
Rebecca Louise Kanis
Emma Louise Mcdonagh
Original Assignee
Zindaclin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zindaclin Limited filed Critical Zindaclin Limited
Publication of SK6322003A3 publication Critical patent/SK6322003A3/sk
Publication of SK288111B6 publication Critical patent/SK288111B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
SK632-2003A 2000-11-28 2001-11-28 Dermatological formulations SK288111B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029018.9A GB0029018D0 (en) 2000-11-28 2000-11-28 Dermatological formulations
PCT/GB2001/005257 WO2002043739A2 (en) 2000-11-28 2001-11-28 Dermatological formulations containing clindamycin and a zinc-salt

Publications (2)

Publication Number Publication Date
SK6322003A3 SK6322003A3 (en) 2003-12-02
SK288111B6 true SK288111B6 (sk) 2013-08-02

Family

ID=9904040

Family Applications (1)

Application Number Title Priority Date Filing Date
SK632-2003A SK288111B6 (sk) 2000-11-28 2001-11-28 Dermatological formulations

Country Status (25)

Country Link
US (2) US20040109902A1 (da)
EP (1) EP1347765B1 (da)
JP (1) JP4272425B2 (da)
KR (1) KR100629326B1 (da)
AT (1) ATE321560T1 (da)
AU (2) AU2002223091B2 (da)
BR (1) BR0115727A (da)
CA (1) CA2429205C (da)
CZ (1) CZ305272B6 (da)
DE (1) DE60118441T2 (da)
DK (1) DK1347765T3 (da)
ES (1) ES2263689T3 (da)
GB (1) GB0029018D0 (da)
HK (1) HK1059218A1 (da)
HR (1) HRP20030433B1 (da)
HU (1) HUP0400520A3 (da)
IL (1) IL152720A0 (da)
MX (1) MXPA03004733A (da)
NZ (1) NZ526170A (da)
PL (1) PL207221B1 (da)
PT (1) PT1347765E (da)
RU (1) RU2277419C2 (da)
SK (1) SK288111B6 (da)
WO (1) WO2002043739A2 (da)
ZA (1) ZA200305012B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EA201000860A1 (ru) * 2007-11-30 2010-12-30 Новартис Аг С-с-алкилимидазолбисфосфонаты
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN109498564B (zh) * 2018-12-21 2021-04-16 贵州景峰注射剂有限公司 一种克林霉素磷酸酯配液及其制备方法
US20230000892A1 (en) * 2021-06-30 2023-01-05 Kenneth Okafor Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
JPS6251619A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd 外用ゲル製剤
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
CA2184828C (en) * 1994-03-28 2008-08-12 Shanta M. Modak Composition for inactivating irritants in fluids
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
WO2002043739A3 (en) 2003-05-01
JP4272425B2 (ja) 2009-06-03
HRP20030433A2 (en) 2004-08-31
HUP0400520A3 (en) 2012-08-28
GB0029018D0 (en) 2001-01-10
HK1059218A1 (en) 2004-06-25
EP1347765A2 (en) 2003-10-01
US20100173855A1 (en) 2010-07-08
PL362279A1 (en) 2004-10-18
HRP20030433B1 (en) 2007-10-31
CA2429205A1 (en) 2002-06-06
ATE321560T1 (de) 2006-04-15
CA2429205C (en) 2010-11-16
AU2309102A (en) 2002-06-11
NZ526170A (en) 2006-01-27
BR0115727A (pt) 2003-10-14
PT1347765E (pt) 2006-08-31
SK6322003A3 (en) 2003-12-02
CZ305272B6 (cs) 2015-07-15
HUP0400520A2 (hu) 2004-07-28
US8268790B2 (en) 2012-09-18
KR20030069793A (ko) 2003-08-27
DE60118441T2 (de) 2006-11-16
AU2002223091B2 (en) 2006-08-31
EP1347765B1 (en) 2006-03-29
PL207221B1 (pl) 2010-11-30
WO2002043739A2 (en) 2002-06-06
JP2004517829A (ja) 2004-06-17
US20040109902A1 (en) 2004-06-10
IL152720A0 (en) 2003-06-24
ES2263689T3 (es) 2006-12-16
DE60118441D1 (de) 2006-05-18
KR100629326B1 (ko) 2006-09-29
CZ20031491A3 (cs) 2004-01-14
ZA200305012B (en) 2005-04-26
DK1347765T3 (da) 2006-08-07
RU2277419C2 (ru) 2006-06-10
MXPA03004733A (es) 2005-02-14

Similar Documents

Publication Publication Date Title
US8268790B2 (en) Dermatalogical formulations
JP5529539B2 (ja) 医薬組成物
US9339551B2 (en) Diclofenac topical formulation
PT626844E (pt) Composicoes de clindamicina e peroxido de benzoilo para o tratamento de acne
JP2008542260A (ja) 新規の注射可能組成物及びその調製方法
JP2019501215A (ja) 局所皮膜形成スプレー
KR20150127256A (ko) 눈의 후안부로의 약물 전달을 위한 안구용 제제
EP1046395B1 (en) Plaster for topical use containing heparin and diclofenac
AU2002223091A1 (en) Dermatological formulations containing clindamycin and a zinc-salt
AU2007332222A1 (en) Pour on formulation
US20070213406A1 (en) Anti-Inflammatory Analgesic External Aqueus Liquid Preparation
PT2204174E (pt) Processo de solubilização do metronidazol com o auxílio de niacinamida e de dois glicóis, a solução assim obtida
CN103550150A (zh) 改进的含二甲基硅油的注射剂
RU2409346C2 (ru) Водный гель для местного применения высокой стабильности на основе метронидазола и способ его получения
JPS63287721A (ja) 消炎鎮痛ゲル剤
EP3342397A1 (en) A pharmaceutical spray dosage form comprising naproxen and lidocaine free base
RU2548714C2 (ru) Фармацевтическая композиция для лечения угревой болезни и способ ее получения
EA018384B1 (ru) Композиция дигидрата 3-(2,2,2-триметилгидразиниум) пропионата для наружного местного применения
RU2281102C2 (ru) Фармацевтическая композиция с антиаллергическим и противовоспалительным действием
RU2530644C2 (ru) Противоугревая фармацевтическая композиция и способ ее получения
EP4247386A1 (en) Flumazenil formulations for subcutaneous injection and methods of treatment using gaba receptor modulators
JP2003160489A (ja) オンダンセトロン経皮吸収用医薬組成物
JP2020055773A (ja) 油性外用液
BR112019017223A2 (pt) macrolídeos contendo triazol e seus usos oftálmicos

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: STRAKAN INTERNATIONAL LIMITED, HAMILTON, BM

Free format text: FORMER OWNER: KANFORD B. V., ROTTERDAM, NL; ACCESS PHARMACEUTICALS, INC., DALLAS, TX, US

Effective date: 20110907

PC4A Assignment and transfer of rights

Owner name: ZINDACLIN LIMITED, KNUTSFORD, CHESHIRE, GB

Free format text: FORMER OWNER: STRAKAN INTERNATIONAL LIMITED, HAMILTON, BM

Effective date: 20130507

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130619